Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs

ClinicalTrials.gov ID: NCT00477230

Public ClinicalTrials.gov record NCT00477230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic Atrial Fibrillation (AF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to compare two types of treatment for atrial fibrillation (AF) that are designed to treat the symptoms of atrial fibrillation. The treatments being compared are: * A single catheter ablation procedure with the investigational EAS, a visually-guided, light-energy catheter * Standard drug therapy (antiarrhythmic drugs) To learn more about the CardioFocus ENABLE investigational clinical study, please contact the study site closest to you. Eligibility Criteria Persons with paroxysmal atrial fibrillation may be eligible for this study. Other study eligibility criteria include: * 18 to 80 years of age * Frequent episodes of AF * Failed at least 1 drug treatment for AF (beta-blockers or standard AADs) * Other criteria

Study identification

NCT ID
NCT00477230
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CardioFocus
Industry
Enrollment
64 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
May 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
Jun 27, 2012

2007 – 2009

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
18
Facility City State ZIP Site status
Arizona Arrhythmia Consultants Scottsdale Arizona 85260 —
Mercy General Hospital Sacramento California 95819-3633 —
University of California at San Francisco San Francisco California 94143 —
St. John's Health Center Santa Monica California — —
Palm Beach Heart Research Institute Atlantis Florida 33462 —
Florida Hospital Orlando Florida — —
Indiana University, Krannert Institute of Cardiology Indianapolis Indiana 46202 —
Genesis Medical Center Davenport Iowa — —
University of Michigan Ann Arbor Michigan 48109 —
William Beaumont Hospital Royal Oak Michigan — —
St. Luke's-Roosevelt New York New York — —
Strong Memorial Hosptial - University of Rochester Rochester New York 14627 —
Ohio State University Columbus Ohio 43210 —
University of Pennsylvania Hospital Philadelphia Pennsylvania 19096 —
Texas Cardiac Arrhythmia Research Austin Texas 78705 —
The Methodist Hospital Houston Texas 77030 —
University of Virginia Charlottesville Virginia — —
Sentara Cardiovascular Research Institute Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00477230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2012 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00477230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →